379 related articles for article (PubMed ID: 30570369)
21. Apelin/APJ system: A critical regulator of vascular smooth muscle cell.
Luo X; Liu J; Zhou H; Chen L
J Cell Physiol; 2018 Jul; 233(7):5180-5188. PubMed ID: 29215755
[TBL] [Abstract][Full Text] [Related]
22. The role of apelinergic system in metabolism and reproductive system in normal and pathological conditions: an overview.
Mehri K; Hamidian G; Zavvari Oskuye Z; Nayebirad S; Farajdokht F
Front Endocrinol (Lausanne); 2023; 14():1193150. PubMed ID: 37424869
[TBL] [Abstract][Full Text] [Related]
23. Apelin/APJ system in inflammation.
Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S
Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524
[TBL] [Abstract][Full Text] [Related]
24. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism.
Dogra S; Neelakantan D; Patel MM; Griesel B; Olson A; Woo S
Mol Cancer Res; 2021 Sep; 19(9):1534-1545. PubMed ID: 34172534
[TBL] [Abstract][Full Text] [Related]
25. Apelin C-Terminal Fragments: Biological Properties and Therapeutic Potential.
Pisarenko OI; Studneva IM
Biochemistry (Mosc); 2023 Nov; 88(11):1874-1889. PubMed ID: 38105205
[TBL] [Abstract][Full Text] [Related]
26. Apelin receptors: From signaling to antidiabetic strategy.
Chaves-Almagro C; Castan-Laurell I; Dray C; Knauf C; Valet P; Masri B
Eur J Pharmacol; 2015 Sep; 763(Pt B):149-59. PubMed ID: 26007641
[TBL] [Abstract][Full Text] [Related]
27. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential.
Pang B; Jiang YR; Xu JY; Shao DX; Hao LY
Eur J Pharmacol; 2023 Jun; 949():175727. PubMed ID: 37062502
[TBL] [Abstract][Full Text] [Related]
28. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
Wu L; Chen L; Li L
Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
[TBL] [Abstract][Full Text] [Related]
29. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
Lv D; Li H; Chen L
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
[TBL] [Abstract][Full Text] [Related]
30. The apelin/APJ signaling system and cytoprotection: Role of its cross-talk with kappa opioid receptor.
Ilaghi M; Soltanizadeh A; Amiri S; Kohlmeier KA; Shabani M
Eur J Pharmacol; 2022 Dec; 936():175353. PubMed ID: 36306927
[TBL] [Abstract][Full Text] [Related]
31. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
[TBL] [Abstract][Full Text] [Related]
32. Expression of apelin and apelin receptor (APJ) in porcine ovarian follicles and in vitro effect of apelin on steroidogenesis and proliferation through APJ activation and different signaling pathways.
Rak A; Drwal E; Rame C; Knapczyk-Stwora K; Słomczyńska M; Dupont J; Gregoraszczuk EL
Theriogenology; 2017 Jul; 96():126-135. PubMed ID: 28532828
[TBL] [Abstract][Full Text] [Related]
33. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
34. Apelin/APJ system: A key therapeutic target for liver disease.
Lv SY; Cui B; Chen WD; Wang YD
Oncotarget; 2017 Dec; 8(67):112145-112151. PubMed ID: 29340118
[TBL] [Abstract][Full Text] [Related]
35. The G protein-coupled receptor ligand apelin-13 ameliorates skeletal muscle atrophy induced by chronic kidney disease.
Enoki Y; Nagai T; Hamamura Y; Osa S; Nakamura H; Taguchi K; Watanabe H; Maruyama T; Matsumoto K
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):553-564. PubMed ID: 36562292
[TBL] [Abstract][Full Text] [Related]
36. Xiaoyaosan Improves Depressive-Like Behaviors in Mice through Regulating Apelin-APJ System in Hypothalamus.
Yan Z; Jiao H; Ding X; Ma Q; Li X; Pan Q; Wang T; Hou Y; Jiang Y; Liu Y; Chen J
Molecules; 2018 May; 23(5):. PubMed ID: 29751542
[No Abstract] [Full Text] [Related]
37. Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling.
Yokoyama Y; Sekiguchi A; Fujiwara C; Uchiyama A; Uehara A; Ogino S; Torii R; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2018 Oct; 70(10):1661-1672. PubMed ID: 29676521
[TBL] [Abstract][Full Text] [Related]
38. Apelin and apelin receptor at different stages of corpus luteum development and effect of apelin on progesterone secretion and 3β-hydroxysteroid dehydrogenase (3β-HSD) in pigs.
Różycka M; Kurowska P; Grzesiak M; Kotula-Balak M; Tworzydło W; Rame C; Gregoraszczuk E; Dupont J; Rak A
Anim Reprod Sci; 2018 May; 192():251-260. PubMed ID: 29576467
[TBL] [Abstract][Full Text] [Related]
39. Apelin/APJ system: A novel potential therapy target for kidney disease.
Huang Z; Wu L; Chen L
J Cell Physiol; 2018 May; 233(5):3892-3900. PubMed ID: 28796300
[TBL] [Abstract][Full Text] [Related]
40. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
Liu Y; Wang L; Shi H
Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
